vimarsana.com
Home
Live Updates
Seamless Therapeutics Launches with $12.5M Seed Financing to
Seamless Therapeutics Launches with $12.5M Seed Financing to
Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases
Seed round co-led by Wellington Partners and Forbion, with non-dilutive funding from BMBF GO-Bio enables maturation of platform and pipeline towards first clinical evaluation Seamless Therapeutics
Related Keywords
Germany ,
Boston ,
Massachusetts ,
United States ,
Wellington ,
New Zealand General ,
New Zealand ,
Netherlands ,
Singapore ,
German ,
Dennis Riedl ,
Technische Universit ,
Frank Buchholz ,
Felix Lansing ,
Oxford Immunotec ,
Dmitrij Hristodorov ,
Desmond James Stephanie ,
Roche Ventana ,
Dean Of Research ,
Perkinelmer ,
Trophic Communications ,
Boston Scientific ,
University Cancer Center ,
Wellington Partners ,
Medical Systems Biology ,
Chief Scientific Officer ,
Seamless Therapeutics Both ,
Chief Executive Officer ,
Seamless Therapeutics ,
Managing Partner ,
United Nations Principles ,
Biogeneration Ventures ,
James Stephanie May ,
Seamless ,
Herapeutics ,
Aunches ,
Need ,
Financing ,
Advance ,
Ransformative ,
Gene ,
Editing ,
Platform ,
Ased ,
Programmable ,
Precision ,
Designer ,
Ecombinases ,